ADC BIOTECHNOLOGY
ADC Bio is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer drugs. The technology signals faster, simpler and less costly development for an exciting new family of drugs.
ADC BIOTECHNOLOGY
Industry:
Biopharma Biotechnology Health Care
Founded:
2010-01-01
Address:
Saint Asaph, Denbighshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.adcbio.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)7739 754337
Total Funding:
16.33 M GBP
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Gravity Forms Adobe Enterprise Cloud HostEurope DNS Host Europe
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Current Employees Featured
Founder
Investors List
Development Bank of Wales
Development Bank of Wales investment in Venture Round - ADC Biotechnology
Seneca Partners
Seneca Partners investment in Venture Round - ADC Biotechnology
Maven Capital Partners
Maven Capital Partners investment in Venture Round - ADC Biotechnology
Downing Ventures
Downing Ventures investment in Venture Round - ADC Biotechnology
Downing LLP
Downing LLP investment in Venture Round - ADC Biotechnology
Maven Capital Partners
Maven Capital Partners investment in Venture Round - ADC Biotechnology
Seneca Partners
Seneca Partners investment in Venture Round - ADC Biotechnology
Development Bank of Wales
Development Bank of Wales investment in Venture Round - ADC Biotechnology
Acceleris Capital
Acceleris Capital investment in Venture Round - ADC Biotechnology
InvestingZone
InvestingZone investment in Venture Round - ADC Biotechnology
Official Site Inspections
http://www.adcbio.com
- Host name: 172.67.199.93
- IP address: 172.67.199.93
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ADC Biotechnology"
ADC Biotechnology - Crunchbase Company Profile
ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.See details»
Sterling Pharma Solutions acquires ADC Bio
Apr 6, 2021 Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology (ADC Bio), a UK …See details»
ADC Biotechnology Company Profile 2024: Valuation, Investors ...
ADC Biotechnology General Information Description. Developer of new conjugation technologies designed to offer new antibody-drug conjugates. The company has developed a patented …See details»
ADC BIO - Craft
ADC BIO is a biotechnology company specializing in antibody-drug conjugates. It uses Lock-Release technology, a system that controls aggregation at source and is scalable and capable …See details»
ADC Bio acquired, focus on Pfizer, Gilead, AZ, Daiichi deals
Apr 15, 2021 Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), has acquired ADC Biotechnology (ADC Bio), a UK based company …See details»
Sterling Pharma Solutions Confirms ADC Bio Acquisition
Apr 6, 2021 The acquisition follows the strategic investment by contract development and manufacturing organization (CDMO), Sterling, in December 2020. Through the acquisition, the …See details»
Sterling Pharma Solutions acquires ADC Bio - Nepic
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology (ADC Bio), a UK based bioconjugation …See details»
Sterling Pharma Solutions acquires ADC Bio - PharmiWeb.com
Apr 8, 2021 Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology (ADC Bio), a UK …See details»
Sterling Pharma Solutions acquires ADC Bio
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation …See details»
ADC Biotechnology - VentureRadar
ADC Bio is developing new process technology to speed, simplify and significantly lower the costs of the conjugation process to produce new antibody... ... Find out ...See details»
Sterling Pharma Solutions acquires ADC Bio - Samedan
The Deeside, Wales, UK facility will rebrand to become part of the Sterling Pharma Solutions international network. Together the teams will establish a centre of excellence for …See details»
Sterling Pharma Solutions acquires ADC Bio - GHO Capital
Apr 7, 2021 Global Contract Development and Manufacturing Organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based …See details»
ADC Bio: CDMOs driving conjugate innovation - Bioprocess Insider
Jul 16, 2019 The contract development and manufacturing organization (CDMO) began constructing the 6,500 m 2 bioconjugation facility in 2017 and once fully operational it will …See details»
ADC Bio Developing Downstream Bioconjugation Process
Feb 14, 2018 ADC Bio is an innovative biotechnology company developing new process technology to speed, simplify and significantly lower the production costs of the latest …See details»
Sterling Pharma Solutions Confirms ADC Bio Acquisition
Apr 6, 2021 Sterling Pharma Solutions has announced its acquisition of ADC Biotechnology, a bioconjugation development services business specializing in antibody drug conjugates …See details»
ADC Bio - Glyndwr Innovations
Case Study ADC Bio ADCBIO is an innovative biotechnology company, developing new process technology to speed, simplify and significantly lower the production costs of the latest …See details»
Sterling Pharma Solutions acquires ADC Bio
Apr 7, 2021 Sterling Pharma Solutions has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services business specialising in antibody drug …See details»
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management. The investment syndicate consists of Maven Capital …See details»
The Evolving Shape of the ADC Market: The Widening Application …
Mar 4, 2019 By Charlie Johnson, CEO of ADC Bio, adcbio.com. The scale of patient demand has fuelled an overarching healthcare market need to expand the drug development pipeline …See details»
CDMO, CMO, Contract Development and Manufacturing …
Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, provides API and ADC services. Read more...See details»